Lung cancer

Photo

News • Early detection

Lung cancer screening: ESR welcomes release of NELSON trial results

The publication of the results of the Dutch-Belgian lung cancer screening trial (NELSON) supports recent calls to introduce lung cancer screening programmes throughout Europe. In light of the scientific evidence, lung cancer screening should be firmly embedded in any initiative launched by the European Commission and the Member States in the fight against cancer. As the leading cause of death…

Photo

News • Early detection

Support for lung cancer screening gains momentum in Scotland

The need to consider a formal recommendation on early screening for lung cancer was acknowledged by the Cross Party Group for Cancer, held at the Scottish Parliament in Edinburgh in January. Attended by over 40 people representing patients, the medical community, and the pharmaceutical industry as well as political advisers and Members of the Scottish Parliament, the Group agreed to write to the…

Photo

News • Personalized diagnostics

AI checks effectiveness of immunotherapy

Scientists from the Case Western Reserve University digital imaging lab use Artificial Intelligence (AI) to predict which lung-cancer patients will benefit from expensive immunotherapy. This is done by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy…

Photo

News • European awareness

Call for greater EU focus on lung cancer

Under the auspices of the Member of the European Parliament (MEP) Claudia Gamon, the European Society of Radiology (ESR), the European Respiratory Society (ERS) and Lung Cancer Europe (LuCE) have joined forces to organise an event at the European Parliament and publish a factsheet that aims to raise awareness of lung cancer and the need for increased visibility of the disease in European Union…

Photo

Article • Lung cancer early diagnosis

Can we afford not to offer lung screening?

For lung cancer patients, life expectancy has hardly improved since 1970. A ten-year survival is 5%, making this the leading cause of death among all cancers. One reason is that, in most cases, the disease is diagnosed far too late. Professor Mathias Prokop is among leading advocates of low-dose CT screening for lung cancer for high risk patients.

Photo

Video • Strategic partnership

Unlocking the full potential of EarlyCDT Lung in US

Oncimmune Holdings plc, a leading global immunodiagnostics group, announces it has entered into an exclusive partnership agreement which it believes will unlock the full potential of EarlyCDT Lung in the United States, bringing this lung cancer test to more patients as a result. This agreement with Biodesix, Inc., a leading lung cancer diagnostic solutions company, encompasses both the…

Photo

News • Encyclopaedia

'Fingerprint database' helps to identify new cancer culprits

Scientists from King's and Cambridge have developed a catalogue of DNA mutation ‘fingerprints’ that could help doctors pinpoint the environmental culprit responsible for a patient’s tumour – including showing some of the fingerprints left in lung tumours by specific chemicals found in tobacco smoke. Our DNA, the human genome, comprises of a string of molecules known as nucleotides. These…

Photo

Article • Radiomics

A boost for thoracic radiology

A new radiomics study could help unlock one of the more challenging issues facing thoracic radiologists. Distinguishing non-small cell lung cancer from benign nodules is a major challenge due to their similar appearance on CT images. Now, however, researchers from Case Western Reserve University in Cleveland, Ohio, have used radiomic features extracted from CT images to differentiate between…

Photo

News • Precancerous lesions

Lung cancer: early detection with molecular profiling

Before lung cancer develops, precancerous lesions are found in the airway, but only half of these will actually become lung cancer, while others will disappear or remain benign without becoming harmful. Under the microscope, the lesions look the same, making it difficult to know which lesions to treat. In this study, published in Nature Medicine, researchers have for the first time, discovered…

Photo

News • Promising research

First steps towards a new, targeted lung cancer treatment

Scientists have identified a key molecular player in a subtype of lung cancer which could lead to a new way to tackle the disease, according to research published in Nature Communications. They found lung squamous cell carcinoma (LUSC) cells contained high amounts of a protein called BCL11A. The study showed that manipulating the gene responsible for the protein stopped the development of LUSC in…

Photo

News • Analyzing free-floating DNA

Blood test shows potential for early detection of lung cancer

A test that analyzes free-floating DNA in the blood may be able to detect early-stage lung cancer, a preliminary report from the ongoing Circulating Cell-Free Genome Atlas (CCGA) study suggests. Lead study author Geoffrey R. Oxnard, MD, of Dana-Farber Cancer Institute: “There is an unmet need globally for early-detection tests for lung cancer that can be easily implemented by health-care…

Photo

News • PET-scan

Imaging agent helps predicting lung cancer therapy success

With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford. The researchers developed a PET scan-compatible imaging agent engineered to seek out a specific mutation found in nonsmall cell lung cancer (which accounts for about 80 percent of lung cancers), bind to…

Photo

News • CancerSEEK

Single blood test screens for 8 cancer types

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer. The test, called CancerSEEK, is a unique noninvasive, multianalyte test that simultaneously evaluates levels of eight cancer proteins and the presence of cancer gene mutations from circulating DNA in the blood. The test is aimed at…

Photo

News • Delivery options

Radiosurgery vs. whole-brain radiation in lung cancer patients with multiple brain metastases

Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique to deliver radiation can be controversial. Whole-brain radiation therapy, as its name suggest, treats the entire brain but can be…

Photo

News • Combination approach

Radiation treatment extends life expectancy for patients with inoperable lung cancer

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiation therapy.

Photo

News • Breath Biopsy platform

Owlstone Medical CEO Billy Boyle wins Royal Academy of Engineering’s Silver Medal

Billy Boyle, Founder and CEO of Owlstone Medical, a diagnostics company developing a breathalyzer for disease, is to be awarded the Royal Academy of Engineering’s prestigious Silver Medal. The award recognizes engineer Billy’s work in spearheading the development of the company’s Breath Biopsy platform and driving a vision to save 100,000 lives and $1.5 billion in healthcare costs.

Photo

Article • Xenon MRT

A revolution in lung function diagnostics

Since lung diseases tend to be complex, imaging is a crucial diagnostic tool. While computed tomography has become the standard modality, which is frequently used outside hospital settings, specialised MRI diagnostics remains the preserve of large university medical centres.

Photo

News • video-assisted thoracoscopic

Revolutionary surgery for lung cancer

The University of Montreal Hospital Research Centre (CRCHUM) is launching a major international clinical trial to test a minimally invasive and safer surgical approach for patients with lung cancer: video-assisted thoracoscopic (VATS) lobectomy with ultrasonic pulmonary artery sealing.

Photo

Microfluidic device tests effects of electric fields on cancer cells

Researchers at Massachusetts Institute of Technology research center in Singapore have developed a new microfluidic device that tests the effects of electric fields on cancer cells. They observed that a range of low-intensity, middle-frequency electric fields effectively stopped breast and lung cancer cells from growing and spreading, while having no adverse effect on neighboring healthy cells.

Photo

News • Lung cancer

“Liquid biopsy” blood test detects genetic mutations

A simple blood test can rapidly and accurately detect mutations in two key genes in non-small cell lung tumors, researchers at Dana-Farber Cancer Institute and other institutions report in a new study – demonstrating the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting those mutations.

62 show more articles
Subscribe to Newsletter